@prefix np: . @prefix npx: . @prefix ns1: . @prefix ns2: . @prefix ns3: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { ns1:identify . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4", "S&T TWOC version 3" . sub:_version prov:value "2"^^xsd:integer . sub:assertion prov:generatedAtTime "2023-07-20T09:47:01.792324"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4692-1377; prov:wasDerivedFrom . rdf:OBJECT rdfs:label "four randomized controlled trials ( RCTs , with another longer-term follow-up of one RCT ) and 63 observational studies" . rdf:OBJECT-POSITION rdfs:label "(63, 77)" . rdf:PREDICATE rdfs:label "identified" . rdf:PREDICATE-POSITION rdfs:label "249, 259" . rdf:SUBJECT rdfs:label "A systematic review of Scopus , Web of Science , Pubmed Central , clinical trial databases and recent international rheumatology conferences for interventional and observational studies reporting the effectiveness of DMARDs in Takayasu arteritis ( TAK )" . rdf:SUBJECT-POSITION rdfs:label "(63, 77)" . rdf:Statement rdfs:label "A systematic review of Scopus, Web of Science, Pubmed Central, clinical trial databases and recent international rheumatology conferences for interventional and observational studies reporting the effectiveness of DMARDs in Takayasu arteritis (TAK) identified four randomized controlled trials (RCTs, with another longer-term follow-up of one RCT) and 63 observational studies." . rdfs:ABSTRACT-UID ns3:50 "fcy3fn4c" . rdfs:TRIPLE-UID ns2:fcy3fn4c-TRIPLE-ABSTRACT-5 "fcy3fn4c-TRIPLE-ABSTRACT-5" . rdfs:label "clinical trial" . rdfs:label "term" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "PG+1UxxqN/Aw2OqRai+uh9ud+F5fACFx6sAFAaa3zpvfEulDnBkCL2A3zQT8Y0CsgozagtQwsPBEmp3gsoQfUDRw9dEouYN5fa6EiuSIUoLUJ1T/M87v+dHYA28NMPOt219mSujD+7dshwKyddJu+ek8zxLRQ4CRx6mdZX8uFrTCJGfjUDCJ/dEwBloULpS/hUPfyqqyyD5dEjVVusITljjerdPO5AGvmErcA6jw9Q847VNpWltmVKAI4DnwPyjmBIASxHHByn96LZSrFW+VcGEi5v+yieIieP9lkvk0l6m9dLFfed6S6V9wZ12DhqByXpgfBRq4i3WVDXaUzlc0npdXD6QZOwswfX4jPxVeS6gE9qSjCG0Q032EYvbCldFeP863FZUnyn0DqrcQCpR35GkzGC5sB9Dnx9XKKsw68Cw80vJoWIBBEyd5ncm5smH2NlfJlShTB6RF6OkduH2V+QC5lEU28jG6Od7wgttN1eM5IriOrIaS02oEDl9+MHra"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }